Current Pharmaceutical Design,volume 9,issue 14  (01-2003)

Period of time： 2003年14期

Publisher： Bentham Science Publishers

Founded in： 1995

Total resources： 625

E-ISSN： 1873-4286|9|14

ISSN： 1381-6128

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Pharmaceutical Design,volume 9,issue 14

Menu

Preface (Hot Topic: New Frontiers and ”Pitfalls“ in Cytokine and Anti-cytokine Therapies Executive Editor: Atsushi Oda)

Current Pharmaceutical Design,volume 9,issue 14 , Vol. 9, Iss. 14, 2003-05 , pp. i-ii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Preface (Hot Topic: New Frontiers and ”Pitfalls“ in Cytokine and Anti-cytokine Therapies Executive Editor: Atsushi Oda)

Current Pharmaceutical Design,volume 9,issue 14 , Vol. 9, Iss. 14, 2003-05 , pp. ii-ii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis

Current Pharmaceutical Design,volume 9,issue 14 , Vol. 9, Iss. 14, 2003-01 , pp. 1095-1126

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease

Current Pharmaceutical Design,volume 9,issue 14 , Vol. 9, Iss. 14, 2003-05 , pp. 1107-1113

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Granulocyte Colony-stimulating Factor as the Expecting Sword for the Treatment of Severe Sepsis

Current Pharmaceutical Design,volume 9,issue 14 , Vol. 9, Iss. 14, 2003-05 , pp. 1115-1120

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Pleiotropic Effects of Cytokines on Acute Myocardial Infarction: G-CSF as A Novel Therapy for Acute Myocardial Infarction

Current Pharmaceutical Design,volume 9,issue 14 , Vol. 9, Iss. 14, 2003-05 , pp. 1121-1127

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Therapeutically-induced Autoantibodies in Patients Treated with Recombinant Hematopoietic Growth Factors: A Brief Summary

Current Pharmaceutical Design,volume 9,issue 14 , Vol. 9, Iss. 14, 2003-05 , pp. 1129-1132

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Clinical Trials Targeting Advanced Cancers by Active Immunization of T-cell Defined Tumor Antigens

Current Pharmaceutical Design,volume 9,issue 14 , Vol. 9, Iss. 14, 2003-05 , pp. 1133-1138

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Clinical Aspects of Clara Cell 10-kDa Protein / Uteroglobin (Secretoglobin 1A1)

Current Pharmaceutical Design,volume 9,issue 14 , Vol. 9, Iss. 14, 2003-05 , pp. 1139-1149

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 9 item(s)